Literature DB >> 10354594

Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?

T F Schulz1, P S Moore.   

Abstract

Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, the most recently discovered human tumor virus, is involved in the pathogenesis of Kaposi's sarcoma, primary effusion lymphoma and some cases of multicentric Castleman's disease. It is non-pathogenic in the majority of otherwise healthy individuals but highly oncogenic in the context of HIV-1 infection and iatrogenic immune suppression, and other cofactors might exist. Several viral genes can interfere with normal cell growth and differentiation, but their precise role in oncogenesis is still under investigation.

Entities:  

Mesh:

Year:  1999        PMID: 10354594     DOI: 10.1016/s0966-842x(99)01495-x

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  8 in total

1.  Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis-associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma-associated herpesvirus.

Authors:  Timothy M Rose; Jonathan T Ryan; Emily R Schultz; Brian W Raden; Che-Chung Tsai
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.

Authors:  Ke Lan; Daniel A Kuppers; Erle S Robertson
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.

Authors:  Antonino Carbone; Ethel Cesarman; Annunziata Gloghini; Hans G Drexler
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

4.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Molecular indications for in vivo integration of the avian leukosis virus, subgroup J-long terminal repeat into the Marek's disease virus in experimentally dually-infected chickens.

Authors:  I Davidson; R Borenshtain; H J Kung; R L Witter
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

6.  The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.

Authors:  Jie Lu; Subhash C Verma; Qiliang Cai; Erle S Robertson
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

7.  Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.

Authors:  Ke Lan; Daniel A Kuppers; Subhash C Verma; Nikhil Sharma; Masanao Murakami; Erle S Robertson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.

Authors:  Ke Lan; Daniel A Kuppers; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.